Osaki Y - Search Results

1

Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score.

Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T. Kudo M, et al. Among authors: osaki y. Hepatology. 2004 Dec;40(6):1396-405. doi: 10.1002/hep.20486. Hepatology. 2004. PMID: 15565571

2

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

Kudo M, Chung H, Osaki Y. Kudo M, et al. Among authors: osaki y. J Gastroenterol. 2003;38(3):207-15. doi: 10.1007/s005350300038. J Gastroenterol. 2003. PMID: 12673442 Review.

3

[Comparison of treatment methods for hepatocellular carcinoma--based on JIS score].

Kudo M, Chung H, Osaki Y, Kasugai H, Oka H, Seki T. Kudo M, et al. Among authors: osaki y. Gan To Kagaku Ryoho. 2004 Dec;31(13):2100-4. Gan To Kagaku Ryoho. 2004. PMID: 15628751 Review. Japanese.

4

A proposal of the modified liver damage classification for hepatocellular carcinoma.

Chung H, Kudo M, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y. Chung H, et al. Among authors: osaki y. Hepatol Res. 2006 Feb;34(2):124-9. doi: 10.1016/j.hepres.2005.10.009. Epub 2005 Dec 27. Hepatol Res. 2006. PMID: 16377236

5

Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.

Toyoda H, Kumada T, Osaki Y, Oka H, Urano F, Kudo M, Matsunaga T. Toyoda H, et al. Among authors: osaki y. Clin Gastroenterol Hepatol. 2006 Dec;4(12):1528-36. doi: 10.1016/j.cgh.2006.09.021. Clin Gastroenterol Hepatol. 2006. PMID: 17162244

6

Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive alpha-fetoprotein.

Oka H, Saito A, Ito K, Kumada T, Satomura S, Kasugai H, Osaki Y, Seki T, Kudo M, Tanaka M; Collaborative Hepato-Oncology Study Group of Japan. Oka H, et al. Among authors: osaki y. J Gastroenterol Hepatol. 2001 Dec;16(12):1378-83. doi: 10.1046/j.1440-1746.2001.02643.x. J Gastroenterol Hepatol. 2001. PMID: 11851836

7

Clinical characteristics of NonBNonC- HCC: Comparison with HBV and HCV related HCC.

Hatanaka K, Kudo M, Fukunaga T, Ueshima K, Chung H, Minami Y, Sakaguchi Y, Hagiwara S, Orino A, Osaki Y. Hatanaka K, et al. Among authors: osaki y. Intervirology. 2007;50(1):24-31. doi: 10.1159/000096309. Epub 2006 Nov 24. Intervirology. 2007. PMID: 17164554

8

Role of tumor markers in assessment of tumor progression and prediction of outcomes in patients with hepatocellular carcinoma.

Toyoda H, Kumada T, Osaki Y, Oka H, Kudo M. Toyoda H, et al. Among authors: osaki y. Hepatol Res. 2007 Sep;37 Suppl 2:S166-71. doi: 10.1111/j.1872-034X.2007.00181.x. Hepatol Res. 2007. PMID: 17877479

9

Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients.

Kasugai H, Osaki Y, Oka H, Kudo M, Seki T; Osaka Liver Cancer Study Group. Kasugai H, et al. Among authors: osaki y. Oncology. 2007;72 Suppl 1:72-5. doi: 10.1159/000111710. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087185

10

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T. Ikeda K, et al. Among authors: osaki y. Ann Intern Med. 2007 May 1;146(9):649-56. doi: 10.7326/0003-4819-146-9-200705010-00008. Ann Intern Med. 2007. PMID: 17470833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

659 results

Search Page

Filters